BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10427875)

  • 1. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico.
    Lazcano-Ponce EC; Moss S; Alonso de Ruíz P; Salmerón Castro J; Hernández Avila M
    Arch Med Res; 1999; 30(3):240-50. PubMed ID: 10427875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach.
    Lazcano-Ponce EC; Buiatti E; Nájera-Aguilar P; Alonso-de-Ruiz P; Hernández-Avila M
    Cancer Causes Control; 1998 May; 9(3):241-51. PubMed ID: 9684704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study.
    Hernández-Avila M; Lazcano-Ponce EC; de Ruíz PA; Romieu I
    Int J Epidemiol; 1998 Jun; 27(3):370-6. PubMed ID: 9698122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervical cancer screening: knowledge of Pap smear benefits and utilization in Mexico].
    Aguilar-Perez JA; Leyva-López AG; Angulo-Nájera D; Salinas A; Lazcano-Ponce EC
    Rev Saude Publica; 2003 Feb; 37(1):100-6. PubMed ID: 12488926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to cervical cancer screening in rural Mexico.
    Watkins MM; Gabali C; Winkleby M; Gaona E; Lebaron S
    Int J Gynecol Cancer; 2002; 12(5):475-9. PubMed ID: 12366665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to early detection of cervical-uterine cancer in Mexico.
    Lazcano-Ponce EC; Castro R; Allen B; Nájera P; Alonso de Ruíz PA; Hernández-Avila M
    J Womens Health; 1999 Apr; 8(3):399-408. PubMed ID: 10326994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
    Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cervical cancer screening program in Mexico: problems with access and coverage.
    Lazcano-Ponce EC; Nájera-Aguilar P; Buiatti E; Alonso-de-Ruiz P; Kuri P; Cantoral L; Hernández-Avila M
    Cancer Causes Control; 1997 Sep; 8(5):698-704. PubMed ID: 9328191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The factors that determine participation in cervical cancer screening in the state of Morelos].
    Lazcano-Ponce EC; Moss S; Cruz-Valdez A; Alonso de Ruiz P; Casares-Queralt S; Martínez-León CJ; Hernández-Avila M
    Salud Publica Mex; 1999; 41(4):278-85. PubMed ID: 10624139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitude and practice of the pap smear as a screening procedure among nurses in a tertiary hospital in north eastern India.
    Thippeveeranna C; Mohan SS; Singh LR; Singh NN
    Asian Pac J Cancer Prev; 2013; 14(2):849-52. PubMed ID: 23621250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.